Court Opinion

ID: 4110263
Source: CourtListenerOpinion
Date Created: 2016-12-22 17:03:01.254414+00
Date Added: 2024-06-11T14:07:05.051603
License: Public Domain

IN THE
            ARIZONA COURT OF APPEALS
                             DIVISION ONE

                       NADIR ISHAK, Petitioner,

                                      v.

  THE HONORABLE CRANE MCCLENNEN, Judge of the SUPERIOR
   COURT OF THE STATE OF ARIZONA, in and for the County of
               MARICOPA, Respondent Judge,

     CITY OF MESA PROSECUTOR'S OFFICE, Real Party in Interest.

                          No. 1 CA-SA 16-0134
                            FILED 12-22-2016

 Petition for Special Action from the Superior Court in Maricopa County
                          No. LC2016-000140-001
                  Mesa Municipal Court No. 2014046117
              The Honorable Crane McClennen, Judge, Retired

           JURISDICTION ACCEPTED; RELIEF GRANTED

                              COUNSEL

Nadir Ishak, Mesa
Petitioner

Mesa City Prosecutor's Office, Mesa
By W. Craig Jones
Counsel for Real Party in Interest
                  ISHAK v. HON. MCCLENNEN/MESA
                          Opinion of the Court

                                  OPINION

Presiding Judge Diane M. Johnsen delivered the opinion of the Court, in
which Judge Lawrence F. Winthrop joined. Judge Randall M. Howe
concurred in part and dissented in part.

J O H N S E N, Judge:

¶1            We address in this special action the affirmative defense a
medical marijuana cardholder may raise when charged with driving under
the influence pursuant to Arizona Revised Statutes ("A.R.S.") section 28-
1381(A)(3) (2016).1 The Arizona Medical Marijuana Act ("AMMA") grants
an affirmative defense to a defendant charged under § 28-1381(A)(3) who
can show he or she is authorized to use medical marijuana and "that the
concentration of marijuana or its impairing metabolite in [his or her body]
was insufficient to cause impairment." Dobson v. McClennen, 238 Ariz. 389,
393, ¶ 23 (2015). We grant relief to the petitioner in this case because the
municipal court erred when it precluded evidence that he has an AMMA
card. We vacate the petitioner's conviction and remand for further
proceedings consistent with this opinion.

                 FACTS AND PROCEDURAL HISTORY

¶2             Police stopped petitioner Nadir Ishak at seven p.m. one day
after they saw his car drift several inches into the next lane. An officer
smelled marijuana as he approached Ishak's car. Ishak told the officer he
had been talking to his passenger and when he realized his car had moved
into the other lane, he guided it back in place. The officer testified that when
Ishak removed his sunglasses, he saw that Ishak's eyes were bloodshot and
"watery." In response to the officer's query about when he had last smoked
marijuana, Ishak replied that he had done so upon awakening that
morning. Ishak performed several field sobriety tests, and during one of
the tests, he experienced "body tremors and eye tremors."

¶3            The State charged Ishak with driving while "impaired to the
slightest degree" under A.R.S. § 28-1381(A)(1) and driving with marijuana
or its metabolite "in [his] body" under A.R.S. § 28-1381(A)(3). Before trial,
the State moved in limine to preclude evidence that Ishak possessed a

1      Absent material revision after the date of an alleged offense, we cite
a statute's current version.

                                       2
                  ISHAK v. HON. MCCLENNEN/MESA
                          Opinion of the Court

medical marijuana card. Ishak objected, arguing the jury should not be
misled "into thinking that it's actually illegal for him to ingest" marijuana.
In a ruling entered before the supreme court decided Dobson, the municipal
court granted the State's motion, reasoning that evidence of Ishak's medical
marijuana card was irrelevant to the charges against him.

¶4             At trial, the arresting officer related that he had seen Ishak's
car drift into the adjacent lane and described how Ishak performed on the
field sobriety tests. The State also called an expert who testified that a
sample of Ishak's blood taken after the stop contained a concentration of
26.9 ng/ml of the marijuana metabolite THC. The court, however,
sustained Ishak's objection that the State's expert lacked foundation to
testify whether those results showed a THC level "that causes impairment
in the person." For his part, Ishak called an expert who testified there "is no
consensus" about the concentration of THC that causes impairment. As for
the reading of 26.9 ng/ml, Ishak's expert testified, "It's a high number and
it can impair some people, but I can't tell you that number . . . will impair
all people."

¶5           The jury acquitted Ishak of driving while impaired under §
28-1381(A)(1) but convicted him of driving while marijuana or its
metabolite was in his body under § 28-1381(A)(3). The municipal court
sentenced Ishak to 180 days' incarceration, suspending half the term.

¶6           By the time Ishak appealed his conviction to the superior
court, our supreme court had decided Dobson. Based on that case, the
superior court concluded that even if the municipal court erred by barring
Ishak from mentioning his medical marijuana card, the error was harmless
because Ishak has "not shown that he would have been able to obtain an
expert who would have been willing to testify that [he] would not have
been impaired at 26.9 ng/ml."

                              JURISDICTION

¶7            We accept jurisdiction of Ishak's petition for special action
because he has "no equally plain, speedy, and adequate remedy by appeal,"
Ariz. R.P. Spec. Act. 8(a), and because his case presents "an issue of
statewide importance potentially affecting numerous DUI cases," Cicoria v.
Cole, 222 Ariz. 428, 430, ¶ 9 (App. 2009); see Dobson, 238 Ariz. at 391, ¶ 6.

                               DISCUSSION

¶8            In reviewing the merits of a superior court decision in a
special action, we determine whether the court committed an error of law

                                      3
                  ISHAK v. HON. MCCLENNEN/MESA
                          Opinion of the Court

or whether the record lacks substantial support for its decision. Files v.
Bernal, 200 Ariz. 64, 65, ¶ 2 (App. 2001). We review de novo questions of
statutory interpretation. Dobson, 238 Ariz. at 391, ¶ 7.

¶9              Under A.R.S. § 28-1381(A)(3), and as relevant here, a person
may be convicted of driving while under the influence if the person has
marijuana "or its metabolite" in his or her body. Construing the statute
"sensibly," however, our supreme court has clarified that § 28-1381(A)(3)
does not proscribe driving with "any byproduct" of marijuana in one's body.
State v. Harris, 234 Ariz. 343, 345, ¶¶ 13, 14 (2014). Instead, the statute makes
it a crime for a person to drive with a metabolite that is "capable of causing
impairment." Id. at 347, ¶ 24. Such an interpretation is consistent with the
legislature's overarching intent to "prevent and punish impaired driving."
Id. at 346, ¶ 19.

¶10           In Dobson, the court took up the cases of two medical
marijuana cardholders convicted of driving in violation of § 28-1381(A)(3).
At issue was a provision in the AMMA that grants broad immunity to a
cardholder who "does not possess more than the allowable amount of
marijuana." A.R.S. § 36-2811(B)(1) (2016); see Dobson, 238 Ariz. at 391, ¶ 8.
The court pointed out that the immunity the AMMA grants to a qualifying
patient, while broad, "is not absolute." Dobson, 238 Ariz. at 391, ¶ 9. The
court cited A.R.S. § 36-2802(D) (2016), which expressly allows prosecution
of a medical marijuana cardholder in some circumstances, with one
important limitation:

       This chapter does not authorize any person to engage in, and
       does not prevent the imposition of any civil, criminal or other
       penalties for engaging in, the following conduct:

                                *       *      *

       D. Operating, navigating or being in actual physical control
       of any motor vehicle . . . while under the influence of
       marijuana, except that a registered qualifying patient shall not be
       considered to be under the influence of marijuana solely because of
       the presence of metabolites or components of marijuana that appear
       in insufficient concentration to cause impairment.

(Emphasis added.) See Dobson, 238 Ariz. at 391, ¶ 9.

¶11          Dobson rejected both the State's contention that § 36-2802(D)
does not apply to a prosecution under § 28-1381(A)(3) and the defendants'
contention that the statute confers an absolute immunity from a

                                       4
                  ISHAK v. HON. MCCLENNEN/MESA
                          Opinion of the Court

prosecution under § 28-1381(A)(3). 238 Ariz. at 392, ¶¶ 13-15. Instead, the
court concluded that, when charged with violating § 28-1381(A)(3), a
"patient may establish an affirmative defense to such a charge by showing
that his or her use was authorized by the AMMA . . . and that the marijuana
or its metabolite was in a concentration insufficient to cause impairment."
238 Ariz. at 393, ¶ 20. As with other affirmative defenses, such a defendant
"bears the burden of proof . . . by a preponderance of the evidence." Id.,
citing A.R.S. § 13-205 (2016).

¶12             Under Dobson, the municipal court in this case erred by
precluding Ishak from offering evidence to support the premise of a
cardholder's affirmative defense under § 36-2802(D) – that because he was
authorized to use medical marijuana, the mere presence of a marijuana
metabolite in his bloodstream was not a violation of A.R.S. § 28-1381(A)(3).
Moreover, based on the record before us, had the court allowed Ishak to
offer evidence of his AMMA card, we cannot say that a properly instructed
jury would have rejected his affirmative defense. Although the arresting
officer testified Ishak displayed some symptoms of impairment during field
sobriety tests, Ishak's counsel vigorously cross-examined the officer,
suggesting other explanations for the behaviors the officer observed.
Ishak's expert also testified that Ishak's performance on the field sobriety
tests did not prove he was under the influence of marijuana. As for Ishak's
blood test results, the jury heard no testimony that the concentration of
THC in Ishak's blood was sufficient to cause impairment in all persons, in
most persons, or even that, to a reasonable degree of scientific certainty, it
proved that Ishak was impaired. Moreover, in acquitting Ishak of the § 28-
1381(A)(1) charge, the jury specifically found the State had not proven
beyond a reasonable doubt that Ishak was "impaired to the slightest
degree."

¶13           The State, however, argues Ishak was not prejudiced by the
preclusion of his medical marijuana card because he offered no evidence
that the concentration of THC in his blood was insufficient to cause
impairment in any human being. The State contends § 36-2802(D) requires
a cardholder in Ishak's position to offer expert testimony that the
concentration of THC in the sample result is "insufficient . . . to cause
impairment in people generally," or "in any person," without regard to
whether the defendant actually was impaired at the time of the stop. The
State argues that in this inquiry, evidence of how that defendant was
driving, or how he or she looked, acted or performed when stopped is not
relevant. According to the State, Ishak's belief as to whether his driving was
influenced by his use of marijuana is likewise irrelevant. Rather, the State

                                      5
                  ISHAK v. HON. MCCLENNEN/MESA
                          Opinion of the Court

asserts "[t]he question is one involving scientific or technical knowledge,
not one rationally based on a witness's perception."

¶14            Neither the AMMA nor Dobson, however, requires a medical
marijuana cardholder charged with violating § 28-1381(A)(3) to offer proof
that the concentration of THC in his or her blood was insufficient to cause
impairment "in people generally" or in any person. To the contrary, unless
and until some law establishes a non-rebuttable level of THC at which a
driver is presumed to be impaired, the affirmative defense available to a
qualifying AMMA cardholder charged with violating § 28-1381(A)(3)
requires proof that he or she was not actually impaired, not whether, in the
abstract, the same THC concentration could not impair any human being.

¶15           That much is clear from the language of § 36-2802(D), which,
under Dobson, is the basis for a medical marijuana user's "affirmative
defense to an (A)(3) charge." 238 Ariz. at 391, ¶ 11. Under the first part of
the single sentence that constitutes § 36-2802(D), the State may prosecute a
cardholder who operates a motor vehicle "while under the influence of
marijuana." The second part of the sentence defines the affirmative defense
the supreme court identified in Dobson: A cardholder "shall not be
considered to be under the influence of marijuana solely because of the
presence of metabolites or components of marijuana that appear in
insufficient concentration to cause impairment." Given the premise of a
cardholder's potential liability under § 36-2802(D) (i.e., whether the
cardholder drove "while under the influence of marijuana"), the affirmative
defense as construed by Dobson does not require proof of the effect of the
defendant's THC level on a hypothetical driver; instead, the focus of the
affirmative defense must be on the effect of the THC concentration on the
defendant cardholder.

¶16           Further supporting this conclusion is the reality that, at
present, there is no presumptive impairment limit established by law, and,
according to the evidence here, there is no scientific consensus about the
concentration of THC that generally is sufficient to impair a human being.
See Harris, 234 Ariz. at 347, ¶ 22 ("unlike alcohol, there is no generally
applicable concentration that can be identified as an indicator of
impairment for illegal drugs"). In acknowledging that fact, Dobson did not
conclude, as the State argues, that the qualified immunity the AMMA
affords is worthless to a cardholder who is unable to offer an expert's
opinion that the concentration of THC in his or her body is insufficient to
impair anyone. To the contrary, in concluding that the absence of a
scientific consensus "argues in favor of assigning the burden" to the
cardholder, the court explained that "[t]he risk of uncertainty in this regard

                                      6
                 ISHAK v. HON. MCCLENNEN/MESA
                         Opinion of the Court

should fall on the patients, who generally know or should know if they are
impaired and can control when they drive, rather than on the members of
the public whom they encounter on our streets." 238 Ariz. at 393, ¶ 21. The
court thus made plain that the affirmative defense hinges on whether the
cardholder is impaired, not on whether his or her concentration of THC is
insufficient to impair any other human being.2

¶17           We also do not accept the State's contention that a cardholder
must present expert testimony to establish the affirmative defense. Under
the State's view, the affirmative defense hinges solely on expert witness
testimony about THC concentration; other evidence about whether the
defendant actually was impaired is irrelevant.

¶18           Nothing in the statute or in Dobson, however, requires a
cardholder to present expert testimony (or precludes a cardholder from
offering non-expert testimony) on the question of whether the cardholder
was impaired due to THC. See Ariz. R. Evid. 701 (allowing lay person to
give opinion testimony that is "not based on scientific, technical or other
specialized knowledge"); cf. Esquivel v. Nancarrow, 104 Ariz. 209, 213 (1969)
("lay witnesses who have had a sufficient opportunity to observe a person
may testify as to whether that person appears to be intoxicated"). In
addition to expert witness testimony, a cardholder's own testimony - and,
as appropriate, the testimony of other lay witnesses who were in a position
to observe the cardholder's behavior - may be relevant and admissible for
the purpose of establishing the affirmative defense.

¶19           The Dobson court observed that the defendants there "made
no effort to show that the marijuana in their bodies was in an insufficient
concentration to cause impairment," so that any error in the exclusion of
their medical marijuana cards was harmless, given the defendants' "failure
to offer any evidence" on the point. 238 Ariz. at 393, ¶ 22. If, as the State
argues, § 36-2802(D) requires a cardholder to prove by expert testimony
that the concentration was insufficient to cause impairment in any human
being, the Dobson court could have ended its analysis of prejudice by simply
observing that the defendants offered no such expert testimony; there

2      Our dissenting colleague argues this conclusion renders § 28-
1381(A)(3) superfluous as applied to AMMA cardholders who can prove
they are not impaired. ¶¶ 26-27 infra. If so, that may be the unavoidable
product of a sensible construction of the affirmative defense provision that
the voter-approved AMMA imposed on a long-existing legislative scheme.
That the fit is not perfect does not justify a strained reading of the
affirmative defense set forth in § 36-2802(D).

                                     7
                  ISHAK v. HON. MCCLENNEN/MESA
                          Opinion of the Court

would have been no reason to note the defendants' generalized failure to
offer any evidence to support the affirmative defense.

¶20           In sum, an authorized medical marijuana user charged with
violating § 28-1381(A)(3) may establish the affirmative defense afforded by
§ 36-2802(D) by showing by a preponderance of the evidence that the
marijuana metabolite concentration in his or her system was insufficient to
cause him or her to be impaired at the time he or she operated or was in
actual physical control of a motor vehicle. The cardholder may satisfy that
burden by, inter alia, cross-examining the arresting officer and the State's
expert forensic scientist and/or by offering any admissible evidence
(including his or her own testimony) relevant to proving whether he or she
was impaired at the time of the stop. That evidence may or may not
include, as here, expert testimony that the cardholder's THC concentration
is not always sufficient to cause impairment.

                              CONCLUSION

¶21            For the foregoing reasons, we accept jurisdiction and grant
relief insofar as we vacate Ishak's conviction under § 28-1381(A)(3) and
remand to the municipal court for further proceedings.3

H O W E, Judge, concurring in part, dissenting in part:

¶22           I agree with the Majority that the municipal court erred by
precluding Ishak from presenting his Arizona Medical Marijuana
("AMMA") card in evidence at his trial for driving with a marijuana
metabolite in his body in violation of A.R.S. § 28–1381(A)(3). Ishak was
indeed entitled to present it to establish the affirmative defense recognized
in Dobson v. McClennen, 238 Ariz. 389, 390 ¶ 2, 361 P.3d 374, 375 (2015), that

3      The jury's not-guilty verdict on the charge of violating § 28-
1381(A)(1) (driving while "impaired to the slightest degree") does not mean
that Ishak may not be retried on the (A)(3) charge because the respective
burdens of proof the law imposes in connection with the two charges are
not congruent. In finding Ishak not guilty of the former charge, the jury
found the State had not proved beyond a reasonable doubt that Ishak was
impaired; to support his affirmative defense to the (A)(3) charge, Ishak has
the burden to show by a preponderance of the evidence that he was not
impaired.

                                      8
               ISHAK v. HON. MCCLENNEN/MESA
             Howe, J., Concurring in Part, Dissenting in Part

marijuana or its metabolite was in a concentration insufficient to cause
impairment. I must dissent, however, from the Majority's ruling that the
error prejudiced Ishak.

¶23            The Majority finds that Ishak was prejudiced because it
cannot be certain that had Ishak been allowed to present his AMMA card a
jury would have rejected Ishak's argument that he was not "under the
influence" of marijuana or its metabolite when he was stopped. See supra
¶ 12. This conclusion is based on the Majority's belief that the Dobson
affirmative defense depends on whether the defendant was actually
impaired by marijuana or its metabolite. See supra ¶ 14. This misreads
Dobson and the AMMA immunity provision, A.R.S. § 36–2802(D), however;
the issue is not whether the defendant was actually impaired by marijuana
or its metabolite, but whether the marijuana or its metabolite in the
defendant's blood was in a concentration insufficient to cause impairment
generally. Because Ishak did not present evidence from which a jury could
find that the concentration of marijuana metabolite in his blood was
insufficient to cause impairment generally, he could not have established
the Dobson affirmative defense even if the municipal court had admitted his
AMMA card. The error consequently did not prejudice Ishak, and reversing
his conviction is unwarranted.

¶24           The Dobson affirmative defense does not work as the Majority
suggests. The AMMA creates a presumption that a qualifying patient is
lawfully engaged in the medical use of marijuana if the patient is "in
possession of a registry identification card" and is "in possession of an
amount of marijuana that does not exceed the allowable amount of
marijuana." A.R.S. § 36–2811(A)(1)(a)–(b). This does not immunize a patient
from prosecution for a driving under the influence offense, A.R.S. § 36–
2802(D), but it does mean that "a registered qualifying patient shall not be
considered to be under the influence of marijuana solely because of the
presence of metabolites or components of marijuana that appear in
insufficient concentration to cause impairment," id. Interpreting this
language in Dobson, our supreme court concluded that a patient may
present an affirmative defense to an (A)(3) charge by establishing that (1)
the AMMA authorized the patient to use marijuana and (2) the "marijuana
or its metabolite was in a concentration insufficient to cause impairment."
Dobson, 238 Ariz. at 393 ¶ 20, 361 P.3d at 378. The defendant bears the
burden of proof on the defense. A.R.S. § 13–205(A) ("[A] defendant shall
prove any affirmative defense raised by a preponderance of the evidence.");
Dobson, 238 Ariz. at 393 ¶ 20, 361 P.3d at 378 (recognizing that A.R.S. § 13–
205(A) applies).

                                     9
                ISHAK v. HON. MCCLENNEN/MESA
              Howe, J., Concurring in Part, Dissenting in Part

¶25            Ishak satisfied the first element of the affirmative defense.
Neither party disputed that Ishak could properly use marijuana under the
AMMA, as evidenced by his valid AMMA card. But Ishak has not met the
second element because, as the superior court held, he did not establish that
the THC concentration was insufficient to cause impairment. The State
presented evidence that Ishak had 26.9 ng/ml4 of THC, the actual drug, and
an unknown amount of hydroxy-THC, an impairing metabolite, in his
blood.5 Ishak did not show that the THC concentration was insufficient to
cause impairment, either during Ishak's cross-examination of the State's
expert or his direct examination of his own expert. In fact, neither the State's
expert nor Ishak's expert testified that such an amount was insufficient to
cause impairment. Indeed, the record shows that on cross-examination,
Ishak's expert acknowledged the 26.9 ng/ml level in Ishak's blood was
high. Ishak's expert also testified that such a THC concentration could cause
impairment in many people and that he had read studies where "many"
individuals "dosed" with that level were impaired.

¶26            In concluding that the second element of the defense is
satisfied if the defendant merely shows that the THC or its metabolite
concentration did not actually impair him, the majority blurs the distinction
between an (A)(1) prosecution and an (A)(3) prosecution. For an (A)(1)
prosecution, the State must prove that a defendant is actually impaired, see
A.R.S. § 28–1381(A)(1), but for an (A)(3) prosecution, it must prove,
regardless of actual impairment, that the defendant was "discovered with
any amount of THC or an impairing metabolite in [his] body," State ex rel.
Montgomery v. Harris, 234 Ariz. 343, 347 ¶ 24, 322 P.3d 160, 164 (2014). Under
the majority's view, although an (A)(3) conviction does not deal with actual

4       The AMMA does not set a per se marijuana concentration limit, but
others states have set such limits, which are all notably far less than the
concentration amount here. See Colo. Rev. Stat. Ann. § 42–4–1301(6)(a)(IV)
(5 ng/ml of THC gives permissible inference of being under the influence);
Mont. Code Ann § 61–8–411(1)(a) (5 ng/ml of THC per se limit); Nev. Rev.
Stat. Ann. § 484C.110(3)(g)–(h) (2 ng/ml limit for marijuana and 5 ng/ml
for its metabolite); Ohio Rev. Code Ann. § 4511.19(A)(1)(j)(vii) (2 ng/ml
limit); Pa. Cons. Stat. Ann. § 3802(d)(1) (1 ng/ml per se limit (41 Pa. Bull.
2295)); Wash. Rev. Code Ann. § 46.61.502(1)(b) (5 ng/ml of THC within two
hours of driving is limit).
5      For comparison, the petitioners in Dobson had 8.5 ng/ml and 10
ng/ml of THC in their blood system. See Dobson, 236 Ariz. at 207 n.2, 337
P.3d at 572 n.2, vacated, 238 Ariz. at 389, 361 P.3d at 374.

                                      10
                ISHAK v. HON. MCCLENNEN/MESA
              Howe, J., Concurring in Part, Dissenting in Part

impairment, a defendant may obtain an (A)(3) acquittal by proving that he
was not actually impaired and may prevent the State from obtaining an
(A)(1) conviction if he meets his lower burden of proving that he was not
actually impaired. In other words, in attempting to establish an affirmative
defense for an (A)(3) conviction, the defendant may obtain an (A)(1)
acquittal.

¶27            The Majority's blurring of (A)(1) offenses with (A)(3) offenses
is inconsistent with the historical treatment of driving under the influence
offenses. In the context of cases involving alcohol as the impairing
substance, driving under the influence while actually impaired—(A)(1)
offenses—and driving with an alcohol concentration of .08 or more—A.R.S.
§ 28–1381(A)(2) offenses—are "two separate and distinct offenses." See
Anderjeski v. City Court of Mesa, 135 Ariz. 549, 550, 663 P.2d 233, 234 (1983)
(addressing a prior version of the driving while under the influence
statute). Our supreme court explained that

       [i]t is possible to have less than 0.10 blood alcohol content [6]
       and still be under the influence of intoxicating liquor. Such a
       person would then be guilty of violating [(A)(1)] and not
       [(A)(2)]. On the other hand, a person may have over 0.10 per
       cent blood alcohol content and still not have his driving
       abilities significantly impaired to come within the provisions
       of [(A)(1)].

Id. at 550–51, 663 P.2d at 234–35. The difference between an (A)(1) and (A)(3)
conviction is similar to that between an (A)(1) and (A)(2) conviction. A
person may be actually impaired by marijuana and be guilty of (A)(1), yet
have a concentration insufficient to cause impairment generally and be not
guilty of (A)(3). And conversely, as in this case, Ishak may not be actually
impaired and be not guilty of (A)(1), yet have a THC concentration of 26.9
ng/ml—an admittedly high number—and be guilty of (A)(3). The
Majority's analysis, however, precludes Ishak and any person with a high
level of THC or its metabolite from conviction for an (A)(3) violation if they
are not actually impaired. This makes (A)(3)—which was designed to
permit conviction without regard to actual impairment—a nullity. This
effect directly contradicts our supreme court's statement in Dobson that
"§ 36–2802(D) does not shield registered qualifying patients from
prosecution under (A)(3)." 238 Ariz. at 392 ¶ 17, 361 P.3d at 377.

6     The statutory alcohol concentration limit at the time was .10.
Anderjeski, 135 Ariz. at 550, 663 P.2d at 234 (citing former A.R.S. § 28–692).

                                      11
                ISHAK v. HON. MCCLENNEN/MESA
              Howe, J., Concurring in Part, Dissenting in Part

¶28           Moreover, the Majority's analysis permits different results
depending on the driver's choice of impairing substance. If a person drives
after drinking alcohol and achieves a blood alcohol concentration of .08 or
more, he is guilty of driving under the influence under A.R.S. § 28–
1381(A)(2), even if he can incontrovertibly prove that this alcohol
concentration did not actually impair him. Yet, if the driver ingests
marijuana and achieves a concentration of THC or its metabolite in his
blood that would generally cause impairment, he can be found not guilty
of an (A)(3) charge if he proves that he was not actually impaired. Such a
divergence of outcomes—given the statute's plain goal to punish those who
drive while actually impaired or while having taken substances that cause
impairment, regardless of the type of substance ingested—is nonsensical.
The Majority's analysis is inconsistent with the plain reading of A.R.S. § 36–
2802(D), Dobson, and the purposes of the driving under the influence
statute.

¶29            The majority bases its analysis also on the notion that a
defendant should not be required to present expert testimony to support an
affirmative defense, which would be necessary if a defendant had to prove
that THC or its metabolite in his blood was in a concentration insufficient
to cause impairment. See supra ¶¶ 13–14, 18. But requiring expert testimony
to prove a drug concentration amount is not uncommon within Arizona's
driving while under the influence statutory scheme. In the same driving
while under the influence statute, a person violates A.R.S. § 28–1381(A)(2)
if the person is driving or in actual physical control of a vehicle with a blood
alcohol concentration of .08 or more within two hours of driving or being
in actual physical control of the vehicle. To prove a blood alcohol content
of .08 or more, the State must present expert testimony. Likewise, if a
defendant in a marijuana prosecution wants to present the affirmative
defense that the concentration of THC or its metabolite in his system does
not cause impairment, he must present expert testimony supporting that
defense.

                                      12
               ISHAK v. HON. MCCLENNEN/MESA
             Howe, J., Concurring in Part, Dissenting in Part

¶30           I agree that the municipal court erred by not admitting Ishak's
AMMA card. In my view, however, the error did not prejudice him because
he presented no evidence showing that the THC concentration in his blood
was insufficient to cause impairment. I would deny relief.

                         AMY M. WOOD • Clerk of the Court
                          FILED: AA

                                       13